AARON LABOVE: Open Payments
NPI 1760933139 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$915 in 48 payments from 12 companies in 2025. Trend: 2023 $872 · 2024 $1,067 · 2025 $915
Food & beverage: $915
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $224 |
| Boston Scientific Corporation | 8 | $189 |
| Merck Sharp & Dohme LLC | 6 | $108 |
| Abbott Laboratories | 4 | $78 |
| Kestra Medical Technology Services, Inc. | 2 | $76 |
| Novo Nordisk Inc | 3 | $66 |
| Amgen Inc. | 4 | $62 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $37 |
| Kaneka Medical America LLC | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: LEQVIO, VERQUVO, CARDIOMEMS, Assure WCD, REPATHA, WATCHMAN Access System, Wegovy, WATCHMAN.
Industry payments across TX — which companies pay providers there.
